Lost In Translation: Turning Multi-Omic Chaos Into Clinical Clarity

By Darren Davis, Ph.D.; Deborah Phippard, Ph.D.; and Jie Yang, Ph.D.

Precision medicine increasingly depends on multi-omics, which combines diverse molecular datasets — such as genomic, transcriptomic, proteomic, and cellular information — to create a holistic view of disease biology. Integrating these complex datasets can be challenging, as they are often generated separately by multiple vendors with different platforms, formats, and schedules, leading to fragmentation that can slow research and increase risk.

Precision for Medicine helps overcome these hurdles by offering strategic assay design, consultative guidance, and cohesive workflows that turn fragmented data into meaningful insights. Using high-resolution multiplexing, spatial biology, cytomics, and AI-driven analytics, the organization enables a nuanced understanding of patient-specific biology, disease mechanisms, and therapeutic outcomes. Tools like the proprietary ApoStream® platform allow the capture of viable cells from liquid biopsies, supporting multi-omic profiling even when conventional tissue samples are limited.

By combining laboratory capabilities, clinical trial operations, and AI-powered interpretation, Precision facilitates biomarker discovery, patient stratification, and trial optimization. This integrated, science-focused approach helps sponsors navigate biological complexity, streamline timelines, and make data-driven decisions across oncology, rare diseases, autoimmune conditions, and cell and gene therapy programs.